Drugplain

NDC 49281-286-01

DAPTACEL 5 ug/.5mL

corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen · INJECTION, SUSPENSION

No Recall History

DAPTACEL is a injection, suspension containing corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen at a strength of 5 ug/.5mL. Manufactured by Sanofi Vaccines US Inc..

Key Facts

Brand Name
DAPTACEL
Generic Name
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen
NDC Code (Package)
49281-286-01
NDC Code (Product)
49281-286
Manufacturer
Sanofi Vaccines US Inc.
Strength
5 ug/.5mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA103666
Marketing Start
05/14/2002

Recall History

No Recall History

View Full Drug Page

DAPTACEL — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.